Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 300,852 | 379,606 | 0 | 0 | N/A |
| Marketable Securities | 44,462 | N/A | 0 | 0 | N/A |
| TOTAL | $349,087 | $379,840 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,946 | 1,441 | N/A | N/A | N/A |
| Other Non-Current Assets | 2,301 | 191 | 0 | 0 | 0 |
| TOTAL | $4,247 | $1,632 | $N/A | $N/A | $N/A |
| Total Assets | $353,334 | $381,472 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,440 | 1,488 | 0 | 0 | 0 |
| Accrued Expenses | 7,527 | 3,190 | 0 | 0 | N/A |
| TOTAL | $10,967 | $4,678 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 9,936 | 0 | 0 | N/A |
| Other Non-Current Liabilities | 0 | 13 | 0 | 0 | 0 |
| TOTAL | $N/A | $9,949 | $N/A | $N/A | $N/A |
| Total Liabilities | $10,967 | $14,627 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,458 | 45,445 | N/A | N/A | N/A |
| Common Shares | 5 | 5 | 0 | 0 | N/A |
| Retained earnings | -79,183 | -50,534 | 0 | 0 | N/A |
| Other shareholders' equity | -27 | 0 | 0 | 0 | 0 |
| TOTAL | $342,367 | $366,845 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $353,334 | $381,472 | $0 | $0 | $0 |